Relx PLC ADR
Sentinellis Health Score
7.4/10
$57.9B
$9.4B
22.0x
AI Summary
RELX sells specialized information and analytics to professionals who need data to make decisions—think insurance underwriters assessing risk, scientists accessing research journals, lawyers researching case law, and companies exhibiting products at trade shows [Yahoo Finance]. They combine proprietary databases with algorithms and AI to turn raw information into decision tools, earning revenue through subscriptions and usage fees across their Risk, Scientific/Medical, Legal, and Exhibitions segments.
RELX is a London-headquartered information analytics company serving professional markets worldwide through four divisions: Risk (data for evaluating risk in insurance/healthcare), Scientific/Technical/Medical (journals and data for researchers), Legal (regulatory and business information), and Exhibitions (trade shows and events) [Yahoo Finance]. The company generates $9.4B in annual revenue with strong profitability (21.5% net margin) but faced an 11.4% stock decline over the past month [Yahoo Finance]. RELX trades at 22x earnings with a $57.9B market cap and pays a 2.74% dividend yield [Yahoo Finance].
RELX shows strong profitability and cash generation despite flat revenue, with manageable debt and healthy returns on capital [Yahoo Finance].
Recent News
RELX (RELX) Loses 11.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance· 2026-05-14RELX (RELX) Partners With Cytora to Automate Underwriting Through AI-Enabled Risk Assessment Data
Yahoo Finance· 2026-05-14
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full Relx PLC ADR analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
Other companies you might find interesting
Same sector (Industrials) or comparable health.